Synapse - Elsevier Science, Inc.

Elsevier Science, Inc.

SHERPA: Unknown

People

Herr
Vickers
Russo
Eastham
Jarnagin
Reuter
D'Angelica
Kingham
Ladanyi
Scher

Groups

Surgery (2049)
Department of Medicine (1334)
Urology (1158)
Solid Tumor Oncology Division (829)
Population Sciences Research Program (816)
Survivorship Research (716)
Epidemiology and Biostatistics (685)
Sloan Kettering Institute Faculty (612)
Department of Pathology and Laboratory Medicine (586)
GSK Faculty (582)

Search Within

Results (5503)

Export to EndNote / Excel

Reply by authors

Correspondence

Dason, S.; Wong, N. C.; Donahue, T. F.; Meier, A.; Zheng, J.; Mannelli, L.; Di Paolo, P. L.; Dean, L. W.; McPherson, V. A.; Rosenberg, J. E.; more...
Journal of Urology (2020)

Fulltext@MSK | Save

Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): Results from a randomised, multicentre, open-label, phase 3 study

Journal Article

Dimopoulos, M.; Quach, H.; Mateos, M. V.; Landgren, O.; Leleu, X.; Siegel, D.; Weisel, K.; Yang, H.; Klippel, Z.; Zahlten-Kumeli, A.; more...
Lancet (2020)

Fulltext@MSK | Save

Responding to the challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Perspectives from the Association for Molecular Pathology Infectious Disease Subdivision Leadership

Editorial

Nolte, F. S.; Babady, N. E.; Buchan, B. W.; Capraro, G. A.; Graf, E. H.; Leber, A. L.; McElvania, E.; Yao, J. D. C.
Journal of Molecular Diagnostics (2020)

Fulltext@MSK | Save

Re: Alejandro Sanchez, Helena Furberg, Fengshen Kuo, et al. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: A cohort study. Lancet Oncol 2020;21:283–93: Unraveling the obesity paradox in immunogenic malignancies: A step toward precision oncology?

Correspondence

Singla, N.
European Urology (2020)

Fulltext@MSK | Save

Comparing patient-relevant endpoint with clinical endpoint in a rare disease: The case of metastatic Merkel cell carcinoma treated with avelumab

Meeting Abstract

Bharmal, M.; Nolte, S.; Lebbe, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Pusceddu, S.; Hanna, G. J.; Hassel, J. C.; more...
Value in Health (2020)

Fulltext@MSK | Save

Real-world healthcare resource utilization and total cost of care among US Medicare patients with chronic lymphocytic leukemia receiving first-line ibrutinib vs chemoimmunotherapy

Meeting Abstract

Huang, Q.; Emond, B.; Lafeuille, M. H.; Gupta, D.; Lefebvre, P.; Sundaram, M.; Mato, A.
Value in Health (2020)

Fulltext@MSK | Save

Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: A SEER-Medicare analysis

Meeting Abstract

Stein, E. M.; Latremouille-Viau, D.; Shi, S.; Guerin, A.; Wu, E.; Bonifacio, G.; Cao, X.
Value in Health (2020)

Fulltext@MSK | Save

Myeloid neoplasm with eosinophilia/basophilia and ETV6-ABL1 rearrangements: Cell of origin and response to tyrosine kinase inhibition

Meeting Abstract

Yao, J.; Xu, L.; Aypar, U.; Londono, D.; Gao, Q.; Baik, J.; Dietz, J.; Benayed, R.; Sigler, A.; Yabe, M.; more...
Journal of Molecular Diagnostics (2020)

Fulltext@MSK | Save

Comparison of cancer specific outcomes following minimally invasive and open surgical resection of early stage kidney cancer from a national cancer registry